Back to BIIB Stock Lookup

BIIB Related Hot List

Feb 1, 2011 07:16 AM Biogen Idec (BIIB) Posts Q4 EPS of $1.42; Guides FY11

Jul 20, 2010 07:16 AM Biogen (BIIB) Reports Q2 EPS of $1.31; Raises FY10 EPS Outlook

Feb 9, 2010 07:16 AM Biogen (BIIB) Reports Q4 Adj-EPS of $1.20, Beats by 15c; Guides FY10 Above the Street

Apr 16, 2009 04:02 PM Biogen (BIIB) Reports Q1 EPS of $1.05, Beats by 4c

Oct 29, 2008 06:30 PM Biogen (BIIB) Reports Another Tysabri Brain Disease Case

Oct 21, 2008 07:58 AM Biogen (BIIB) Tops Q3 Views; Guides FY08

Oct 9, 2008 04:04 PM Biogen Idec (BIIB) Said Baminercept Trial Failed To Meet Primary Endpoint

Jul 31, 2008 05:28 PM Biogen (BIIB) and Elan (ELN) Discloses 2 More Cases PML for TYSABRI Patients

Jul 22, 2008 07:34 AM Biogen (BIIB) Tops Q2 View; Guides FY08

Apr 29, 2008 09:32 AM Genentech (DNA) and Biogen Idec (BIIB) Announce Phase II/III of Rituxan Did Not Meet Goals

Feb 6, 2008 07:33 AM Biogen Idec (BIIB) Tops Q4 Views; Guides In-Line

Dec 12, 2007 04:21 PM UPDATE: Biogen Idec (BIIB) Completes Strategic Review Without Sale

Dec 12, 2007 04:16 PM Biogen Idec (BIIB) complete strategic review without sale

Oct 12, 2007 04:56 PM Biogen (BIIB) Is In Play

May 30, 2007 06:58 AM Biogen Idec (BIIB) Announces $3B ''Dutch Auction'' Tender Offer

May 2, 2007 07:18 AM Biogen Idec (BIIB) Misses Q1 EPS by 2c, Reiterates FY07 Guidance

Dec 18, 2006 05:31 PM Biogen Idec (BIIB) and Genentech (DNA) Send Letter to Physicians Saying Patients Taking Rituxan Have Died

Nov 7, 2006 09:57 AM Targeted Genetics (TGEN) Trading Higher After Amending Agreement with Biogen Idec (BIIB)

Oct 31, 2006 07:40 AM Biogen Idec (BIIB) Tops Q3 EPS by 11; Guides Above Street

Oct 19, 2006 10:32 AM Accentia Biopharmaceuticals (ABPI) Study Shows Positive Data for BiovaxID for Patients Whose Cancer has Relapsed after Chemotherapy

Sep 20, 2006 04:43 PM Alnylam Pharmaceuticals (ALNY) In Development Deal with Biogen Idec (BIIB)

Jul 26, 2006 07:41 AM Biogen Idec (BIIB) Tops Q2 EPS by 8c

Jun 5, 2006 01:06 PM Biogen Idec Inc. ( BIIB) and Elan (ELN): Tysabri sales allowed by US regulators to resume - Bloomberg.

Apr 7, 2006 07:03 AM Biogen (BIIB)/Elan (ELN) Said TYSABRI Demonstrate Significant Effects on Quality of Life Measures in MS

Mar 22, 2006 06:46 AM FDA Extends Regulatory Review Period for Biogen Idec (BIIB)/Elan (ELN) for TYSABRI

Mar 8, 2006 03:20 PM BIIB/ELN Confirms FDA Panel Recommendation for TYSABRI Reintroduction

Mar 8, 2006 10:58 AM FDA panel recommends BIIB/ELN Tysabri return to the market - Bloomberg

Mar 1, 2006 06:47 AM FDA Approves DNA/BIIB Rituxan for Rheumatoid Arthritis

Nov 17, 2005 04:46 PM BIIB and ELN Said FDA Accepts SBLA for TYSABRI in MS

Oct 26, 2005 04:08 PM BIIB Missed Q3 EPS by 6 Cents; Guides

Oct 25, 2005 09:05 AM DNA/BIIB Said DNA Grants Priority Review for Rituxan

Oct 17, 2005 08:00 AM ELN and BIIB Said No New Cases on PML in Crohn's and Rheumatoid Arthritis Patients

Sep 26, 2005 04:05 PM BIIB and ELN File sBLA for TYSABRI

Sep 20, 2005 04:08 PM ELN and BIIB Provide an Update on TYSABRI

Sep 8, 2005 04:05 PM BIIB Cuts Workforce By 17%

Aug 26, 2005 08:33 AM ELN and BIIB Lower Related to Comments from Morgan Stanley on Tysabri

Aug 9, 2005 07:01 AM BIIB And ELN Report No New Cases Of PML In Patients Using TYSABRI

Jul 18, 2005 04:20 PM BIIB and ELN Said Phase III TYSABRI Achieved 2-yr Primary Endpoint

Jun 30, 2005 07:09 AM ELN And BIIB Say TYSABRI Meets Endpoints

Jun 16, 2005 04:07 PM DNA Buys BIIB Manufacturing Facility

Jun 13, 2005 07:10 AM Possible Fifth Case of PML Found Linked to Tysabri - WSJ

Jun 9, 2005 12:14 PM Talk of Tysabri Return After NEJM Study Shows That Patients Could Be Monitored for Fatal Disease - Bloomberg

Jun 9, 2005 07:08 AM DNA, BIIB and Roche Announced Preliminary Positive Results from Rituxan

Jun 2, 2005 07:33 AM ELN Down On Reports of Fourth Tysabri Patient w/Deadly Brain Disease

Apr 29, 2005 06:57 AM BIIB Receives Formal SEC Notice

Apr 27, 2005 04:10 PM BIIB Misses Q1 Views

Apr 13, 2005 03:52 PM ELN/BIIB: Presented Positive Data From SENTINEL Trial Evaluating TYSABRI with AVONEX

Apr 12, 2005 04:19 PM ELN/BIIB Says TYSABRI Lowers MS Disability Risk in Trial

Apr 7, 2005 08:10 AM BIIB Said BG-12 Psoriasis Study Meets Primary Endpoint

Apr 6, 2005 06:39 AM DNA And BIIB Announce Rituxan Meets Endpoints

Back to BIIB Stock Lookup